Correlations between Overexpression of SOX2OT Long Non-coding RNA and Susceptibility to Breast Cancer. 2020

Mina Dehghani-Samani, and Naiemeh Hassanzadeh, and Hamidreza Kabiri, and Marzieh Jafari, and Matineh Rahmani G Shahrokhi, and Maryam J Chermahini, and Arvand Akbari, and Esmat Noshadi, and Esmaeil Mahmoudi, and Amela Jusic
Department of Genetics, Faculty of Basic Sciences, Shahrekord University, Shahrekord, Iran.

The SOX2OT lcnRNA has been recognized as a positive regulator in the transcription regulation of the SOX2 gene. Recent studies have approved the dysregulation of SOX2OT lncRNA expression patterns in some common cancer types, including esophageal, lung, and breast cancer. The objective of the present study was to investigate the correlation between overexpression of SOX2OT lcnRNA and susceptibility to breast cancer. SOX2OT lncRNA expression profiling in 15 breast cancer and normal tumour-adjacent breast tissue samples was performed by using qRT-PCR. To evaluate the diagnostic potential of the SOX2OT lncRNA, we performed ROC curve analyses. The expression of SOX2OT lncRNA in patients suffering from breast cancer revealed a significant overexpression in comparison with the healthy group (P<0.001). Significantly, the elevated circulating SOX2OT lncRNA was found specific to breast cancer and could differentiate breast cancer from controls with 100% of both sensitivity and specificity. Based on the Kaplan- Meier analysis, there was no significant correlation between SOX2OT lcnRNA expression and overall survival. The results confirmed the association between breast cancer and higher SOX2OT lncRNA expression. According to the ROC curve results, SOX2OT lcnRNA could be a new measurable indicator of the breast cancer and a potential therapeutic target for breast cancer patients.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D014408 Biomarkers, Tumor Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS. Biochemical Tumor Marker,Cancer Biomarker,Carcinogen Markers,Markers, Tumor,Metabolite Markers, Neoplasm,Tumor Biomarker,Tumor Marker,Tumor Markers, Biochemical,Tumor Markers, Biological,Biochemical Tumor Markers,Biological Tumor Marker,Biological Tumor Markers,Biomarkers, Cancer,Marker, Biochemical Tumor,Marker, Biologic Tumor,Marker, Biological Tumor,Marker, Neoplasm Metabolite,Marker, Tumor Metabolite,Markers, Biochemical Tumor,Markers, Biological Tumor,Markers, Neoplasm Metabolite,Markers, Tumor Metabolite,Metabolite Markers, Tumor,Neoplasm Metabolite Markers,Tumor Markers, Biologic,Tumor Metabolite Marker,Biologic Tumor Marker,Biologic Tumor Markers,Biomarker, Cancer,Biomarker, Tumor,Cancer Biomarkers,Marker, Tumor,Markers, Biologic Tumor,Markers, Carcinogen,Metabolite Marker, Neoplasm,Metabolite Marker, Tumor,Neoplasm Metabolite Marker,Tumor Biomarkers,Tumor Marker, Biochemical,Tumor Marker, Biologic,Tumor Marker, Biological,Tumor Markers,Tumor Metabolite Markers
D015972 Gene Expression Regulation, Neoplastic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue. Neoplastic Gene Expression Regulation,Regulation of Gene Expression, Neoplastic,Regulation, Gene Expression, Neoplastic
D016133 Polymerase Chain Reaction In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships. Anchored PCR,Inverse PCR,Nested PCR,PCR,Anchored Polymerase Chain Reaction,Inverse Polymerase Chain Reaction,Nested Polymerase Chain Reaction,PCR, Anchored,PCR, Inverse,PCR, Nested,Polymerase Chain Reactions,Reaction, Polymerase Chain,Reactions, Polymerase Chain

Related Publications

Mina Dehghani-Samani, and Naiemeh Hassanzadeh, and Hamidreza Kabiri, and Marzieh Jafari, and Matineh Rahmani G Shahrokhi, and Maryam J Chermahini, and Arvand Akbari, and Esmat Noshadi, and Esmaeil Mahmoudi, and Amela Jusic
April 2024, BMC molecular and cell biology,
Mina Dehghani-Samani, and Naiemeh Hassanzadeh, and Hamidreza Kabiri, and Marzieh Jafari, and Matineh Rahmani G Shahrokhi, and Maryam J Chermahini, and Arvand Akbari, and Esmat Noshadi, and Esmaeil Mahmoudi, and Amela Jusic
January 2018, Cancer cell international,
Mina Dehghani-Samani, and Naiemeh Hassanzadeh, and Hamidreza Kabiri, and Marzieh Jafari, and Matineh Rahmani G Shahrokhi, and Maryam J Chermahini, and Arvand Akbari, and Esmat Noshadi, and Esmaeil Mahmoudi, and Amela Jusic
January 2014, PloS one,
Mina Dehghani-Samani, and Naiemeh Hassanzadeh, and Hamidreza Kabiri, and Marzieh Jafari, and Matineh Rahmani G Shahrokhi, and Maryam J Chermahini, and Arvand Akbari, and Esmat Noshadi, and Esmaeil Mahmoudi, and Amela Jusic
March 2017, Biomarkers in medicine,
Mina Dehghani-Samani, and Naiemeh Hassanzadeh, and Hamidreza Kabiri, and Marzieh Jafari, and Matineh Rahmani G Shahrokhi, and Maryam J Chermahini, and Arvand Akbari, and Esmat Noshadi, and Esmaeil Mahmoudi, and Amela Jusic
March 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Mina Dehghani-Samani, and Naiemeh Hassanzadeh, and Hamidreza Kabiri, and Marzieh Jafari, and Matineh Rahmani G Shahrokhi, and Maryam J Chermahini, and Arvand Akbari, and Esmat Noshadi, and Esmaeil Mahmoudi, and Amela Jusic
November 2013, Zhonghua zhong liu za zhi [Chinese journal of oncology],
Mina Dehghani-Samani, and Naiemeh Hassanzadeh, and Hamidreza Kabiri, and Marzieh Jafari, and Matineh Rahmani G Shahrokhi, and Maryam J Chermahini, and Arvand Akbari, and Esmat Noshadi, and Esmaeil Mahmoudi, and Amela Jusic
January 2019, Technology in cancer research & treatment,
Mina Dehghani-Samani, and Naiemeh Hassanzadeh, and Hamidreza Kabiri, and Marzieh Jafari, and Matineh Rahmani G Shahrokhi, and Maryam J Chermahini, and Arvand Akbari, and Esmat Noshadi, and Esmaeil Mahmoudi, and Amela Jusic
February 2018, Experimental and therapeutic medicine,
Mina Dehghani-Samani, and Naiemeh Hassanzadeh, and Hamidreza Kabiri, and Marzieh Jafari, and Matineh Rahmani G Shahrokhi, and Maryam J Chermahini, and Arvand Akbari, and Esmat Noshadi, and Esmaeil Mahmoudi, and Amela Jusic
January 2018, Cancer biomarkers : section A of Disease markers,
Mina Dehghani-Samani, and Naiemeh Hassanzadeh, and Hamidreza Kabiri, and Marzieh Jafari, and Matineh Rahmani G Shahrokhi, and Maryam J Chermahini, and Arvand Akbari, and Esmat Noshadi, and Esmaeil Mahmoudi, and Amela Jusic
January 2021, Frontiers in oncology,
Copied contents to your clipboard!